Recalls / Firms / Caraco Pharmaceutical Laboratories, Ltd.

Caraco Pharmaceutical Laboratories, Ltd.

12 FDA drug recalls on record.

Date	Class	Drug	Status
2014-06-26	Class II	Cephalexin Capsules, USP, 250 mg, packaged in a) 100-count bottles (NDC 62756-293-88) and	Terminated
2014-06-26	Class II	Cephalexin Capsules, USP, 500 mg, packaged in a) 100-count bottles (NDC 62756-294-88) and	Terminated
2014-06-12	Class II	Venlafaxine Hydrochloride Extended-Release Tablets, 150 mg, Rx only, Packaged in 30 Count	Terminated
2014-04-09	Class II	Gemcitabine For Injection USP, 1 g, (lyophilized), For Intravenous Use Only, Sterile Singl	Terminated
2014-04-09	Class III	Cetirizine Hydrochloride	Terminated
2014-04-09	Class III	Cetirizine Hydrochloride	Terminated
2014-03-20	Class II	Venlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, packaged in a) 30-count bottl	Terminated
2014-03-20	Class II	Venlafaxine Hydrochloride Extended-Release Tablets, 150 mg, packaged in a) 30-count bottle	Terminated
2014-01-29	Class II	Oxcarbazepine	Terminated
2014-01-28	Class II	Metformin Hydrochloride	Terminated
2012-11-05	Class II	traMADOL Hydrochloride Tablets, USP 50 mg, 1000-count tablets per bottle, Manufactured by:	Terminated
2012-08-21	Class II	Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Caps	Terminated